The study is an open-label uncontrolled single-center study for the evaluation of the Performance (efficacy and safety) of the dermal filler mARG-01-17 in the facial rejuvenation therapy. The design is of a not blinded, not randomized, single group.
The aim of the clinical investigation is to evaluate the performance of the mARG-01-17 dermal filler in the context of its efficacy and safety.